glp-1 advertising crackdown news FDA issued 25 warning letters to telehealth companies for false and Compounded GLP-1s: Why doctors worry

Anecdotal reports from long-term users in research communities suggest the peptide remains well-tolerated over extended periods

The supply update likely spells the end of widespread GLP-1 compounding in the U.S., which became an immensely popular avenue for patients to access weight loss drugs while Novo and Lillys branded products were in shortage

Born Jason Bradley DeFord, he's gone from being imprisoned multiple times for crimes like drug dealing and aggravated robbery to winning Grammys as a chart-topping musician

Where contouring earns its place is after the weight comes off, when a specific area has not responded the way the rest of the body did

With the food industry being tied to population growth over time, reductions in obesity-related mortality will be a net positive, says Mike Blommer, a food and beverage data specialist at Capital One